BRCA2 C-terminal clamp restructures RAD51 dimers to bind B-DNA for replication fork stability
Molecular Cell · 2025-06 · 85 (11) · 2080-2096.e6
DOI: 10.1016/j.molcel.2025.05.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2025-06. Verfasst von Michael A Longo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular & Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: BRCA2 Protein, Rad51 Recombinase, DNA Replication. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
Tumor suppressor protein breast cancer susceptibility protein 2 (BRCA2) acts with RAD51 in replication fork protection (FP) and homology-directed DNA-break repair (HDR). Critical for cancer etiology and therapy resistance, the BRCA2 C terminus was thought to stabilize recombinogenic RAD51 after the assembly of ATP-extended RAD51 filaments on single-stranded DNA (ssDNA). Here, the detailed crystal structure of the human BRCA2 C-terminal interaction domain (TR2 interface [TR2i]) complexed with ATP-bound RAD51 prior to DNA binding instead reveals TR2i unexpectedly induces a unique ATP-RAD51 dimer conformation that accommodates nucleation onto double-stranded B-DNA unsuited for HDR initiation. Structural, biochemical, and molecular results with interface-guided mutations uncover TR2i's FP mechanism. Proline-driven secondary structure stabilizes residue triads and spans the RAD51 dimer, engaging pivotal interactions of RAD51 M210 and BRCA2 S3291/P3292, the cyclin-dependent kinase (CDK) phosphorylation site that toggles between FP during S phase and HDR in G2. TR2i evidently acts as an allosteric clamp, switching RAD51 from ssDNA to double-stranded and B-DNA binding, enforcing FP over HDR, challenging the current BRCA2-RAD51 dogma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular & Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA.
- The Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
- Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX 77054, USA.
- Poseidon Laboratory, Pasadena, CA 91107, USA.
- The Department of Integrative Structural & Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
- Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIEHS NIH HHS
- National Institutes of Health
- Cancer Prevention and Research Institute of Texas
- Biological and Environmental Research
- Welch Foundation
- UK Research and Innovation Medical Research Council
Zitieren
APA
Longo, M. A., Ahmed, S. M., Chen, Y., Tsai, C. L., Namjoshi, S., Shen, R., Ahmed, Z., Wang, X., Perera, R. L., Arvai, A., Lee, M., Kong, L. R., Engl, W., Ng, W. S., Zhao, Z. W., Venkitaraman, A. R., Tainer, J. A., & Schlacher, K. (2025). BRCA2 C-terminal clamp restructures RAD51 dimers to bind B-DNA for replication fork stability. Molecular Cell, 85(11), 2080-2096.e6. https://doi.org/10.1016/j.molcel.2025.05.010
Vancouver
Longo MA, Ahmed SM, Chen Y, Tsai CL, Namjoshi S, Shen R, et al. BRCA2 C-terminal clamp restructures RAD51 dimers to bind B-DNA for replication fork stability. Molecular Cell. 2025;85(11):2080-2096.e6. doi:10.1016/j.molcel.2025.05.010
BibTeX
@article{Longo2025,
author = {Longo, Michael A and Ahmed, Syed Moiz and Chen, Yue and Tsai, Chi-Lin and Namjoshi, Sarita and Shen, Runze and Ahmed, Zamal and Wang, Xiaoyan and Perera, Rajika L and Arvai, Andy and Lee, Miyoung and Kong, Li Ren and Engl, Wilfried and Ng, Woei Shyuan and Zhao, Ziqing Winston and Venkitaraman, Ashok R and Tainer, John A and Schlacher, Katharina},
title = {BRCA2 C-terminal clamp restructures RAD51 dimers to bind B-DNA for replication fork stability},
journal = {Molecular Cell},
year = {2025},
volume = {85},
number = {11},
pages = {2080--2096.e6},
doi = {10.1016/j.molcel.2025.05.010}
}
EUVIMED